fbpx Skip to main content

Member's Profile

Parvus Therapeutics

800 Dubuque Ave
South San Francisco,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2019
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Parvus Therapeutics
Biotech Company
Parvus Therapeutics Inc. is a privately-held biopharmaceutical company engaged in the development and commercialization of Navacim therapeutics targeting autoimmune diseases. Navacims were discovered by Pere Santamaria, M.D., Ph.D. Chief Scientific Officer and Founder of Parvus, Julia McFarlane/Diabetes Canada Professor of the Cumming School of Medicine at the University of Calgary.
Related News
No related news posted by this Member